SENSEONICS HOLDINGS INC (SENS) Stock Fundamental Analysis
USA - NASDAQ:SENS - US81727U3032 - Common Stock
6.15 USD
+0.25 (+4.24%)
SENS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of SENS is average, but there are quite some concerns on its profitability. SENS is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SENS has reported negative net income.
SENS had a negative operating cash flow in the past year.
SENS had negative earnings in 4 of the past 5 years.
In the past 5 years SENS always reported negative operating cash flow.
1.2 Ratios
SENS has a Return On Assets of -45.39%. This is in the lower half of the industry: SENS underperforms 63.30% of its industry peers.
The Return On Equity of SENS (-72.01%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROIC | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 17.77%, SENS is doing worse than 81.38% of the companies in the same industry.
SENS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
SENS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SENS has more shares outstanding
Compared to 5 years ago, SENS has more shares outstanding
The debt/assets ratio for SENS is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -6.75, we must say that SENS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.75, SENS is doing worse than 69.68% of the companies in the same industry.
SENS has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.37, SENS is in line with its industry, outperforming 48.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -6.75 |
ROIC/WACCN/A
WACC8.55%
2.3 Liquidity
SENS has a Current Ratio of 9.58. This indicates that SENS is financially healthy and has no problem in meeting its short term obligations.
SENS has a better Current ratio (9.58) than 92.55% of its industry peers.
A Quick Ratio of 9.26 indicates that SENS has no problem at all paying its short term obligations.
SENS's Quick ratio of 9.26 is amongst the best of the industry. SENS outperforms 93.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 |
3. Growth
3.1 Past
The earnings per share for SENS have decreased strongly by -861.54% in the last year.
The Revenue has been growing slightly by 0.37% in the past year.
SENS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.08% yearly.
EPS 1Y (TTM)-861.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-975%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
3.2 Future
The Earnings Per Share is expected to grow by 14.87% on average over the next years. This is quite good.
The Revenue is expected to grow by 50.14% on average over the next years. This is a very strong growth
EPS Next Y-1187.15%
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
EPS Next 5Y14.87%
Revenue Next Year62.97%
Revenue Next 2Y68.18%
Revenue Next 3Y63.5%
Revenue Next 5Y50.14%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
SENS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SENS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as SENS's earnings are expected to decrease with -139.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
5. Dividend
5.1 Amount
SENS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:SENS (11/18/2025, 2:04:10 PM)
6.15
+0.25 (+4.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.56%
Inst Owner Change-11.53%
Ins Owners2.78%
Ins Owner Change30.17%
Market Cap250.49M
Revenue(TTM)22.47M
Net Income(TTM)-68.21M
Analysts75.71
Price Target19.3 (213.82%)
Short Float %N/A
Short Ratio0.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.35%
Min EPS beat(2)1.96%
Max EPS beat(2)14.75%
EPS beat(4)3
Avg EPS beat(4)9.2%
Min EPS beat(4)-14%
Max EPS beat(4)34.09%
EPS beat(8)6
Avg EPS beat(8)7.97%
EPS beat(12)7
Avg EPS beat(12)-0.74%
EPS beat(16)11
Avg EPS beat(16)63.45%
Revenue beat(2)2
Avg Revenue beat(2)9.27%
Min Revenue beat(2)8.25%
Max Revenue beat(2)10.29%
Revenue beat(4)4
Avg Revenue beat(4)6.13%
Min Revenue beat(4)2.48%
Max Revenue beat(4)10.29%
Revenue beat(8)7
Avg Revenue beat(8)5.36%
Revenue beat(12)10
Avg Revenue beat(12)4.93%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)1671.56%
PT rev (3m)1693.51%
EPS NQ rev (1m)-1426.9%
EPS NQ rev (3m)-1426.9%
EPS NY rev (1m)-1900.12%
EPS NY rev (3m)-1499.55%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 9.84 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.64 | ||
| P/tB | 2.67 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.25
EYN/A
EPS(NY)-1.86
Fwd EYN/A
FCF(TTM)-1.35
FCFYN/A
OCF(TTM)-1.34
OCFYN/A
SpS0.63
BVpS2.33
TBVpS2.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.77% | ||
| FCFM | N/A |
ROA(3y)-13.99%
ROA(5y)-136.34%
ROE(3y)-16.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.37 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 22.67% | ||
| Cap/Sales | 1.53% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 9.58 | ||
| Quick Ratio | 9.26 | ||
| Altman-Z | -6.75 |
F-Score5
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)70.29%
Cap/Depr(5y)48.74%
Cap/Sales(3y)4.48%
Cap/Sales(5y)3.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-861.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-975%
EPS Next Y-1187.15%
EPS Next 2Y-293.72%
EPS Next 3Y-139.62%
EPS Next 5Y14.87%
Revenue 1Y (TTM)0.37%
Revenue growth 3Y18.01%
Revenue growth 5Y1.08%
Sales Q2Q%89.89%
Revenue Next Year62.97%
Revenue Next 2Y68.18%
Revenue Next 3Y63.5%
Revenue Next 5Y50.14%
EBIT growth 1Y11.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.93%
EBIT Next 3Y12.25%
EBIT Next 5YN/A
FCF growth 1Y21.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.05%
OCF growth 3YN/A
OCF growth 5YN/A
SENSEONICS HOLDINGS INC / SENS FAQ
Can you provide the ChartMill fundamental rating for SENSEONICS HOLDINGS INC?
ChartMill assigns a fundamental rating of 2 / 10 to SENS.
What is the valuation status for SENS stock?
ChartMill assigns a valuation rating of 0 / 10 to SENSEONICS HOLDINGS INC (SENS). This can be considered as Overvalued.
How profitable is SENSEONICS HOLDINGS INC (SENS) stock?
SENSEONICS HOLDINGS INC (SENS) has a profitability rating of 0 / 10.